alexa Ablative Efficacy Of Sequential Intravesical Chemotherapy Using Gemcitabine And Mitomycin-C For Non Invasive Bladder Carcinoma
ISSN: 2161-1076

Surgery: Current Research
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd International Conference on Surgery and Anesthesia
November 17-19, 2014 Chicago, USA

Kumar Jayant, Santosh Kumar, Kalpesh Parmar, RGaneshmoni, Shrawan K Singh and Swati Agrawal
Accepted Abstracts: Surgery Curr Res
DOI: 10.4172/2161-1076.S1.018
Abstract
Introduction: To study ablative efficacy, safety recurrence risk of sequential gemcitabine and mitomycin C intravesical chemotherapy in superficial bladder carcinoma. Secondary objective was to study the effect on tumor recurrence. Materials & Methods: Fifty six patients with non-muscle invasive bladder cancer who were at very high risk ofanesthesia with intermediate/high risk tumor or BCG refractory or intolerant tumor were prospectively enrolled. After documenting the tumor size and site on cystoscopy, intravesical chemotherapy (2g gemcitabine in 50 ml saline for 1 hour followed by 40mg mitomycin C in 50 ml saline for another hour) was given weekly for six weeks. Documentation of the tumor size and site were done on cystoscopy. Close monthly follow up for 8 months was done by cystoscopy after completion of intravesical chemotherapy. Results: Mean patient age was 60.4 yr. The tumor size varied from 0.5 cm to 2 cm (median1.2 cm) with stage Ta/T1 and low/ high grade. Sixteen patients completed the therapy and were evaluated for response. Two of them opted out due to irritative bladder symptoms.Forty six (82.1%) had complete response, 7 had partial response and one expired due to unrelated cause. This is a small study with short follow up (8 months). Further follow up is needed for tumour recurrence. Conclusions: Chemoresection with sequential intravesicalgemcitabine and mitomycinC therapy is a viable option for surgically inaccessible tumor in high risk patients.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords